Semaglutide vs Tirzepatide: Which GLP-1 Is More Effective?

Semaglutide and tirzepatide are the two dominant injectable medications in the current medical weight loss landscape. Both are GLP-1 receptor agonists, but they work differently — and clinical trial data shows meaningful differences in average weight loss outcomes. Understanding these differences helps you have a more informed conversation with your prescribing clinician.

How Semaglutide Works

Semaglutide (brand names Ozempic for diabetes, Wegovy for obesity) mimics the GLP-1 hormone, which regulates appetite and slows gastric emptying. Weekly subcutaneous injection delivers consistent levels over 7 days. Oral semaglutide (Rybelsus) is available but has lower bioavailability.

• Mechanism: GLP-1 receptor agonist (single pathway)
• Dosing: Weekly subcutaneous injection (0.25mg → 2.4mg for weight loss)
• Average weight loss in STEP trials: 14.9% body weight at 68 weeks (Wegovy 2.4mg)
• FDA-approved for: Type 2 diabetes (Ozempic) and chronic weight management (Wegovy)

How Tirzepatide Works

Tirzepatide (brand name Mounjaro for diabetes, Zepbound for obesity) activates both GLP-1 and GIP receptors. GIP (glucose-dependent insulinotropic polypeptide) is a second gut hormone that works synergistically with GLP-1 to enhance appetite suppression and improve metabolic function.

• Mechanism: Dual GLP-1 and GIP receptor agonist (two pathways)
• Dosing: Weekly subcutaneous injection (2.5mg → 15mg)
• Average weight loss in SURMOUNT-1: 20.9% body weight at 72 weeks (15mg dose)
• FDA-approved for: Type 2 diabetes (Mounjaro) and chronic weight management (Zepbound)

Clinical Trial Comparison

Note: These trials were conducted separately with different populations. A head-to-head trial (SURPASS-CVOT vs SUSTAIN comparisons) generally shows tirzepatide producing greater weight reduction, but individual responses vary considerably.

Side Effect Profiles

Both medications share the same core GLP-1 mechanism and therefore similar side effects:

• Nausea (most common during dose escalation)
• Vomiting and diarrhea
• Constipation
• Decreased appetite (the intended effect)
• Injection site reactions

The dual GIP mechanism in tirzepatide does not appear to meaningfully worsen the GI side effect profile based on current trial data. Discontinuation rates for side effects are comparable between the two.

Cost and Access

• Semaglutide: Brand Wegovy carries high list prices, but compounded semaglutide is widely available through telehealth programs at significantly lower cost. FDA enforcement of compounding restrictions has fluctuated — verify current availability with your program.
• Tirzepatide: Brand Zepbound is FDA-approved for weight loss. Compounded tirzepatide has been available through telehealth programs, though regulatory status should be confirmed at enrollment.

Which Should You Choose?

Consider Semaglutide If:

• You have a strong response history to GLP-1 medications
• You want the most extensively studied weight loss medication (STEP trial data is extensive)
• Your clinician is more familiar with semaglutide dosing protocols
• Compounded options are important for cost management and are currently available

Consider Tirzepatide If:

• You want the highest average weight loss ceiling shown in clinical trials
• You have not responded adequately to semaglutide alone
• Your clinician recommends it based on your metabolic profile
• The dual mechanism aligns better with your specific metabolic needs (e.g., insulin resistance)

Frequently Asked Questions

Is tirzepatide always better than semaglutide?

On average in clinical trials, tirzepatide produces greater weight loss. However, individual responses vary — some patients do very well on semaglutide. "Better" depends on your specific biology, not just average trial data.

Can I switch from semaglutide to tirzepatide?

Yes. Many clinicians transition patients who plateau on semaglutide to tirzepatide. This typically involves stopping semaglutide and restarting tirzepatide at its lowest dose after a brief washout discussion with your provider.

Are both available through telehealth?

Both are prescribed through telehealth weight loss programs. Compounded versions of both have been available, though regulatory status can change — confirm with your specific program before enrolling.

Compare GLP-1 Weight Loss Programs →